NRD
CL icon

Nebula Research & Development’s Colgate-Palmolive CL Stock Holding History

Nebula Research & Development’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,326
Closed -$939K – 172
2025
Q2 		$939K Buy
10,326
+6,437
+166% +$588K 0.08% 423
2025
Q1 		$364K Sell
3,889
-1,000
-20% -$89.5K 0.03% 707
2024
Q4 		$444K Sell
4,889
-19,880
-80% -$1.9M 0.05% 598
2024
Q3 		$2.57M Buy
+24,769
New +$2.52M 0.31% 57
2023
Q4 		– Sell
-6,736
Closed -$479K – 668
2023
Q3 		$479K Buy
+6,736
New +$504K 0.25% 139

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nebula Research & Development's CL Position: Q3 2025 in Review

Nebula Research & Development sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 10,326 shares — an estimated $939K sold.

Nebula Research & Development first reported a position in CL in Q3 2023 and held it in 5 quarters. The position peaked at $2.57M in Q3 2024. 1,842 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Nebula Research & Development reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 10,326 Colgate-Palmolive shares in Q3 2025, an estimated $939K.
  • Nebula Research & Development first reported a position in Colgate-Palmolive in Q3 2023 and held it in 5 quarters.
  • Nebula Research & Development's Colgate-Palmolive position peaked at $2.57M in Q3 2024.
  • 1,842 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.